P.O. Box 110287
Research Triangle Park
About Pappas VenturesPappas Ventures is a Research Triangle Park, North Carolina-based venture capital firm that invests nationally in the life science industry. Founded in 1994, Pappas has over $350 million under management, and is currently investing out of its fourthventure capital fund. Among the firm’s more than 40 portfolio companies are FlowCardia, LipoScience, Plexxikon, BrainCells, CeNeRx BioPharma , CoLucid Pharmaceuticals, and TyRx. The firm's primary investment focus is on product-oriented biotechnology and pharmaceutical companies, with a secondary focus on medical technologies.
3 articles with Pappas Ventures
4D Molecular Therapeutics snagged $90 million in a Series B financing round. The company intends to use the funds to advance its Therapeutic Vector Evolution platform and pipeline of next-generation AAV gene therapeutics.